| Genus plc | |
| Type: | Public |
| Foundation: | 1933 |
| Location: | Basingstoke, Hampshire, UK |
| Key People: | Iain Ferguson, Chairman[1] Jorgen Kokke, CEO |
| Industry: | Biotechnology |
| Revenue: | £689.7 million (2023)[2] |
| Operating Income: | £40.5 million (2023) |
| Net Income: | £31.8 million (2023) |
Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]
The company has three divisions:[6]
PIC's pedigree herds sire an estimated 30% of commercially reared pigs.[7]